Summit Therapeutics Inc. (SMMT)
NASDAQ · Healthcare
Summit Therapeutics Inc. Operating Income 2019–2024
Summit Therapeutics Inc. annual/quarterly operating income history and growth rate from 2019 to 2024. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Summit Therapeutics Inc. operating income for the quarter ending September 30, 2024 was -58.4 M, a 184.88% increase year-over-year.
- Summit Therapeutics Inc. operating income for the twelve months ending September 30, 2024 was -631.8 M, a 786.44% increase year-over-year.
- Summit Therapeutics Inc. annual operating income for 2024 was -226.0 M, a 62.93% decrease from 2023.
- Summit Therapeutics Inc. annual operating income for 2023 was -609.6 M, a 745.69% increase from 2022.
- Summit Therapeutics Inc. annual operating income for 2022 was -72.1 M, a 16.36% decrease from 2021.
- Summit Therapeutics Inc. annual operating income for 2021 was -86.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Summit Therapeutics Inc. Operating Income — FAQ
Summit Therapeutics Inc. (SMMT) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Summit Therapeutics Inc.'s operating income?
Summit Therapeutics Inc. (SMMT) reported operating income of -$226M for fiscal 2024.
Where can I see SMMT's operating income history?
The chart and table above show Summit Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.